Presentations

• Managing Your Cap Table – One of the Most Important Company Assets
  May. 9, 2013
  By Yigal Arnon & Co. Law Firm. From a Yigal Arnon & IATI event, 8 May 2013.
• Reimbursement of Innovative Medical Devices in Germany
  Apr. 22, 2013
  By MArS-AHEAD, Germany. From a IATI webinar, April 2013
• Cash is King? Points for Smart Fundraising
  Apr. 1, 2013
  By Adv. Shlomo Ladress, Amit, Pollak, Matalon & Co. From IATI & APM Second Meetup, March 2013.
• Incentives & Challenges in R&D Outsourcing
  Mar. 29, 2013
  By Dror Gonen, Galil Software. From CFO Forum for Hi Tech & Life Science companies, March 2013
• Directors' Roles
  Feb. 17, 2013
  By Guy Preminger, Partner & Technology Leader, PWC Israel. From a IATI VCs rountable: Board Consideration in Exits scenario
• Board Considerations in Exit Scenarios
  Feb. 17, 2013
  By Dr. Giora Yaron, entrepreneur & investor; Chairman Executive Council, Tel Aviv University. From a IATI VCs rountable: Board Consideration in Exits scenario
• Directors' Duties When a Company is Being Acquired (Hebrew)
  Feb. 17, 2013
  By Dan Shamgar, Partner at Meitar Liquornik Geva & Leshem Brandwein. From a IATI VCs rountable: Board Consideration in Exits scenario
• Tax Considerations in Start-up Companies (Hebrew)
  Feb. 17, 2013
  By Dina Pasca-Raz, Senior Manager, KPMG Somekh Chaikin. From a IATI VCs rountable: Board Consideration in Exits scenario
• Strategic Partner: Benefit or Risk?
  Feb. 17, 2013
  By Adv. Erez Mizrachi, Founding Partner, FWMK. From a IATI VCs rountable: Board Consideration in Exits scenario
• R&D Collaborations With Europe
  Jan. 20, 2013
  By Mr. Marcel Shaton, ISERD's CEO
• Employees' compensation for Service Inventions - View from the Trenches (Hebrew)
  Jan. 16, 2013
  By Barry P. Levenfeld - Partner, Yigal Arnon & Co
• Employees' compensation for Service Inventions (Hebrew)
  Jan. 16, 2013
  By Yaky Yanay, VP Finance & CFO, Pluristem
• Employees' compensation for Service Inventions (Hebrew)
  Jan. 16, 2013
  By Asa Kling, Israel Commissioner of Patents & Trademarks
• Legal Considerations & IP in Israeli Life Science Companies (Hebrew)
  Jan. 9, 2013
  By Dr. Adi Gilat, Partner, Head of IP dep., GKH. From a IATI-Deloitte seminar, "From Idea to the Biopharmaceutical Product", June 2012
• The Israeli Economy: HighTech and the Macro-Economic Outlook
  Sep. 9, 2012
  By Gil Michael Buffman, Ph.d., Chief Economist, Bank Leumi (a presentation from IATI HighTec Conference 2012)